What is the medical insurance price of lxazomib? What is the price after reimbursement?

Ixazomib (Ixazomib) is an oral drug that belongs to a class of drugs called proteasome inhibitors (Proteasome Inhibitors). It is used to treat multiple myeloma, a family of leukemias and lymphomas that primarily affects plasma cells in the bone marrow. Ixazomib's mechanism of action involves inhibiting the function of the proteasome, which is critical for the growth and reproduction of cancer cells.

The original drug of Ixazomib has been launched in China and has been included in medical insurance. Patients can purchase it domestically, but the price is still relatively high. The price is about 15,000 to 6,000 yuan. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. Foreign original drugs are even more expensive. The cheaper foreign ones are ixazomib generics, mainly Laotian generics. The price is more than 1,000 yuan, and the ingredients of the original drugs and generic drugs are basically the same.

Ixazomib is a proteasome inhibitor that acts on the intracellular protein degradation system to prevent the growth and reproduction of abnormal plasma cells. Ixazomib slows the progression of multiple myeloma by inhibiting the function of the proteasome, affecting protein degradation and recycling in cancer cells.

Ixazomib is commonly used to treat multiple myeloma and can be used alone or in combination with other drugs to create a comprehensive treatment regimen. Although ixazomib is generally considered more tolerable than some other treatments, it may still cause side effects such as nausea, vomiting, diarrhea, fatigue, anemia, and low platelet counts. Patients need to be regularly monitored and managed by a physician during treatment.

Ixazomib has shown efficacy in clinical trials in patients with multiple myeloma, including extending survival, improving quality of life, and reducing symptoms associated with the disease. Patients typically work with their doctors to develop an individualized treatment plan, including the use of ixazomib as well as other drugs, based on their specific situation and disease stage.